| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/16/2003 | EP1326837A1 Crystal forms of 1- 6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride |
| 07/16/2003 | EP1326832A1 Chemical compounds |
| 07/16/2003 | EP1326831A1 Substituted fused pyrroleimines and pyrazoleimines |
| 07/16/2003 | EP1326830A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 07/16/2003 | EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 07/16/2003 | EP1326826A1 Use of amino acids for treating pain |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses |
| 07/16/2003 | EP1326642A2 Catecholamine pharmaceutical compositions and methods |
| 07/16/2003 | EP1326632A2 Agents for the treatment of viral infections |
| 07/16/2003 | EP1326628A2 Chemokine mutants in the treatment of multiple sclerosis |
| 07/16/2003 | EP1326623A1 Saururus chinensis extract for prevention and treatment of neurodegenerative disease |
| 07/16/2003 | EP1326620A1 S-adenosylmethionine and derivatives thereof for the treatment and prevention of alzheimer's disease |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326616A1 New use of quetiapine |
| 07/16/2003 | EP1326613A1 Use of substituted imidazo 1,2-a]pyridine-, imidazo 1,2-a]pyrimidine and imidazo 1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1326596A1 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease |
| 07/16/2003 | EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS |
| 07/16/2003 | EP1326591A2 Combination of statins and sorbitol dehydrogenase inhibitors |
| 07/16/2003 | EP1224182B1 N-substituted 1-(butyrolactone)-isoquinolines for treating nervous disorders |
| 07/16/2003 | EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 07/16/2003 | EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use |
| 07/16/2003 | EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1054669B1 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | EP1025231B1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
| 07/16/2003 | EP0814793B1 Prilocaine and hydrofluorocarbon aerosol preparations |
| 07/16/2003 | EP0814790B1 Administration of ketamine for detoxification |
| 07/16/2003 | EP0550550B1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 07/16/2003 | CN1430620A Macrolides compound |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430603A Novel bicyclic compounds |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/16/2003 | CN1430597A Novel MMP-2/MMP-9 inhibitors |
| 07/16/2003 | CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/16/2003 | CN1430514A Use of galantamine for treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| 07/16/2003 | CN1430510A Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone |
| 07/16/2003 | CN1430503A O/W emulsion |
| 07/16/2003 | CN1430501A Preparation of injectable suspensions having improved injectabity |
| 07/16/2003 | CN1430474A Tryptophan source from plants and uses therefor |
| 07/16/2003 | CN1429905A Recombination adenopathy adjoint virus carrier capable of controlling digene expression for treating parkinsonism |
| 07/16/2003 | CN1429614A Preparation method of fresh gastrodia whole powder |
| 07/16/2003 | CN1429610A Drug stopping medicine and its preparation method |
| 07/16/2003 | CN1429570A Medicine for dropping-off drug and its preparation method |
| 07/16/2003 | CN1429556A Muscle strong agent and anti-inflammatory agent |
| 07/16/2003 | CN1429546A Application of 4-methyl cyclopentadecanone in manufacture of medicine |
| 07/16/2003 | CN1429498A Health-care food |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114598C Aromatic compounds and pharmaceutical compositions containing them |
| 07/16/2003 | CN1114597C Quinoline derivs |
| 07/16/2003 | CN1114596C Biphenyl derivatives |
| 07/16/2003 | CN1114594C D4 receptor selectivity piperazine derivatives |
| 07/16/2003 | CN1114435C Pill for nourishing yin and its preparing process |
| 07/16/2003 | CN1114429C Ixeris debilis extract preparation and application thereof |
| 07/16/2003 | CN1114420C Medicine for treating intractable ischias and chronic lumbocrural pain and its preparing process |
| 07/16/2003 | CN1114413C Application of emodin-8-0-beta-D-glucoside |
| 07/16/2003 | CN1114407C Use of chelating agent clioquinol for manufacture of pharmaceutical compsn. for treatment of alzheimer's disease |
| 07/16/2003 | CN1114406C Use of (+)-ÔÇÿalphaÔÇÖ-(2,3-dimethyoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating mental depression disorders and bipolar psychonosema disorders |
| 07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593370 Topical capsaicin preparation |
| 07/15/2003 | US6593367 Treatment of addiction and addiction-related behavior |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593353 p53 inhibitors and therapeutic use of the same |
| 07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
| 07/15/2003 | US6593350 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse |
| 07/15/2003 | US6593349 3-(heteroarylamino) indazole, 1,2-benzisothiazole, or 1,2-benzisoxazole derivatives of given formula; for treating nervous system disorders such as pain, anxiety and bipolar disorder |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593336 Methods for treating irritable bowel syndrome |
| 07/15/2003 | US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's |
| 07/15/2003 | US6593330 Compounds and their use |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593325 Method for the treatment of anxiety which comprises administering to a patient in need of such treatment an effective amount of the compound of claim 1 or a pharmaceutically acceptable salt thereof. |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6593301 Ligosaccharide glycosides derived from spirostane with high effective and low side action wherein the dementia is Alzheimer's disease, vascular dementia, or mixed type dementia |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/15/2003 | US6593121 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of nervous system disorders |
| 07/15/2003 | US6592901 Highly compressible ethylcellulose for tableting |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/15/2003 | US6592893 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 07/15/2003 | US6592860 Composition and applicator for topical substance delivery |
| 07/15/2003 | US6592845 Administering 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline to a patient suffering from or at risk of developing ALS in order to reduce symptoms or delay onset of ALS. |
| 07/15/2003 | CA2180843C Pyridine modulators of acetylcholine receptors |
| 07/15/2003 | CA2067408C 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors |
| 07/10/2003 | WO2003056339A1 Screening methods and the use of agents identified using the same |
| 07/10/2003 | WO2003056006A1 Method of detecting mutation in human serotonin receptor subtype 2b gene |
| 07/10/2003 | WO2003055992A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 07/10/2003 | WO2003055984A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 07/10/2003 | WO2003055983A2 Targeted retrograde gene delivery to motor neurons |
| 07/10/2003 | WO2003055915A2 Human netrin receptor and uses thereof |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |